My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Natera, Inc. - Common Stock (NQ:NTRA)

227.54 -3.51 (-1.52%)

Streaming Delayed Price Updated: 10:58 AM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Is the Market Bullish or Bearish on Natera? ↗

April 04, 2025

Via Benzinga

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

March 20, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the immuno-oncology stocks, including Natera (NASDAQ:NTRA) and its peers.

Via StockStory

Topics Artificial Intelligence

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings ↗

March 19, 2025

Via The Motley Fool

1 Mid-Cap Stock to Own for Decades and 2 to Brush Off

March 18, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

How Do Investors Really Feel About Natera? ↗

March 11, 2025

Via Benzinga

Deep Dive Into Natera Stock: Analyst Perspectives (9 Ratings) ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

February 17, 2025

Via Benzinga

Why Is Natera (NTRA) Stock Soaring Today

March 11, 2025

Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 5.2% in the afternoon session after stocks rebounded, following a broad-based sell-off the previous day. The Nasdaq was down 4%, while the...

Via StockStory

Topics Stocks World Trade

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales

February 27, 2025

Genetic testing company Natera (NASDAQ:NTRA). reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 53% year on year to $476.1 million. The company’s full-year revenue...

Via StockStory

Natera (NTRA) Q4 Earnings: What To Expect

February 26, 2025

Genetic testing company Natera (NASDAQ:NTRA). will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4 ↗

February 18, 2025

Billionaire investor Stanley Druckenmiller's family office Duquesne has divested his entire stake in Broadcom, simultaneously increasing his investments in major tech companies, as revealed in a recent...

Via Benzinga

Why NATERA INC (NASDAQ:NTRA) qualifies as a high growth stock. ↗

February 17, 2025

Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing? A fundamental and technical analysis of (NASDAQ:NTRA).

Via Chartmill

$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today ↗

February 06, 2025

Via Benzinga

NATERA INC is setting up nicely for a breakout. ↗

February 17, 2025

Exploring NATERA INC's Technical Signals and Breakout Potential: A technical analysis of NATERA INC (NASDAQ:NTRA) shows it may be setting up for a breakout.

Via Chartmill

The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs ↗

February 14, 2025

In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.

Via Talk Markets

Topics Stocks Stocks / Equities

Small- To Mid-Cap Biotech Trades Poised For Gains ↗

February 01, 2025

On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these...

Via Talk Markets

Topics ETFs Stocks / Equities

Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). ↗

January 24, 2025

Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA).

Via Chartmill

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone ↗

January 21, 2025

The company is working to expand the uses and reimbursement for its blood-based tests for cancer.

Via Investor's Business Daily

Looking Into Natera's Recent Short Interest ↗

January 20, 2025

Via Benzinga

The Analyst Verdict: Natera In The Eyes Of 14 Experts ↗

January 10, 2025

Via Benzinga

Why NASDAQ:NTRA qualifies as a high growth stock. ↗

January 03, 2025

Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing?

Via Chartmill

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗

January 19, 2025

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...

Via Benzinga

The End Of The 60/40 Portfolio ↗

January 17, 2025

Since bonds don't protect against stock declines, it's time for a different approach.

Via Benzinga

Topics Bonds

Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday ↗

January 17, 2025

Via Benzinga

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings ↗

January 09, 2025

Via The Motley Fool

Exploring NASDAQ:NTRA's high growth characteristics. ↗

December 13, 2024

Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).

Via Chartmill

Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next ↗

December 24, 2024

Druckenmiller's Duquesne Family Office sold Nvidia and Palantir stocks while increasing stake in Teva Pharmaceutical, signaling a shift in investment focus.

Via Benzinga

Topics Artificial Intelligence

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings ↗

December 21, 2024

Via The Motley Fool

Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252% ↗

December 20, 2024

Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.